Pharming Group N.V. (PHAR) Stock Analysis — Valuation, Growth & Financial Health

Five-Pillar Analysis for PHAR

TopTier Strategy breaks every stock down into five clear pillars — so you can quickly see what makes Pharming Group N.V. a strong or weak investment candidate.

▲ Valuation

Is PHAR priced fairly?

P/E, EV/EBITDA, P/B, and free cash flow yield — versus sector medians and PHAR's own history. Our valuation engine flags whether Pharming Group N.V. is trading rich, fair, or cheap.

▲ Profitability

How efficient is Pharming Group N.V.?

Gross margin, operating margin, net margin — and how they're trending. Stable or expanding margins signal pricing power; declining margins are an early warning.

▲ Financial Health

Can PHAR survive a downturn?

Debt-to-equity, current ratio, quick ratio, and interest coverage. We screen Pharming Group N.V.'s balance sheet for stress and flag liquidity or leverage risk.

▲ Returns

What's PHAR earning on capital?

Return on Equity, Return on Invested Capital, and Return on Assets. We compare Pharming Group N.V.'s capital efficiency to peers — and check leverage to make sure ROE isn't financial-engineering noise.

▲ Growth

Is Pharming Group N.V. expanding?

Revenue growth, EPS growth, and free cash flow growth — over 1, 3, and 5 years. We separate genuine operating growth from buyback-driven EPS gains.

→ Get the Full Picture

See the complete PHAR breakdown

Sign up free to unlock Pharming Group N.V.'s full five-pillar analysis with live financial data, peer comparisons, and historical context.

Sign up free →

Frequently Asked Questions about PHAR

Quick answers to the most common questions about Pharming Group N.V..

What does Pharming Group N.V. (PHAR) do?

Pharming Group N.V. is a publicly traded company under the ticker symbol PHAR. Sign up to TopTier Strategy to view a full business overview — including segments, competitive position, and how revenue is generated.

How do I analyze PHAR stock?

The five-pillar framework — Valuation, Profitability, Financial Health, Returns, and Growth — is the cleanest way to evaluate any stock, including PHAR. Each pillar uses standardized metrics that let you compare Pharming Group N.V. to its peers and to its own history.

Is PHAR a good stock to buy?

Whether Pharming Group N.V. fits your portfolio depends on your time horizon, risk tolerance, and investing style. TopTier Strategy gives you the structured data — valuation, profitability, balance sheet health, returns on capital, and growth — to make that decision with conviction.

Where can I see PHAR's financial data?

Sign up free at TopTier Strategy to access Pharming Group N.V.'s complete financial profile, including historical metrics, peer comparisons, and our five-pillar score breakdown.

Popular Stocks

Other widely-followed stocks investors research on TopTier Strategy.

Pharming Group N.V. (PHAR)